These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6508277)

  • 41. Future perfect? Presymptomatic diagnosis, neural transplantation, and trophic factors.
    Shults CW
    Neurol Clin; 1992 May; 10(2):567-93. PubMed ID: 1584189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Neural grafting in the aged rat brain.
    Gage FH; Björklund A
    Annu Rev Physiol; 1986; 48():447-59. PubMed ID: 3010821
    [No Abstract]   [Full Text] [Related]  

  • 43. Neurotransplantation: a clinical update.
    Bakay RA
    Acta Neurochir Suppl (Wien); 1993; 58():8-16. PubMed ID: 8109310
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fetal substantia nigra grafts. Effect on dopamine receptors in the rat corpus striatium.
    Korfali E; Knowles WD; Uysal S; Ulus IH; Ozmen T
    Cleve Clin J Med; 1989 May; 56(3):259-62. PubMed ID: 2568188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of nerve growth factor infusion on behavioral recovery and graft survival following intraventricular adrenal medulla grafts in the unilateral 6-hydroxydopamine lesioned rat.
    Bergdall VK; Becker JB
    J Neural Transplant Plast; 1994; 5(3):163-7. PubMed ID: 7727597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Human fetal tissues grafted to rodent hosts: structural and functional observations of brain, adrenal and heart tissues in oculo.
    Olson L; Strömberg I; Bygdeman M; Granholm AC; Hoffer B; Freedman R; Seiger A
    Exp Brain Res; 1987; 67(1):163-78. PubMed ID: 3305059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The adrenal medulla and Parkinson's disease.
    Stoddard SL
    Rev Neurosci; 1994; 5(4):293-307. PubMed ID: 7697198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adrenal medulla grafts enhance functional activity of the striatal dopamine system following substantia nigra lesions.
    Becker JB; Freed WJ
    Brain Res; 1988 Oct; 462(2):401-6. PubMed ID: 3142637
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Histochemical properties of intrastriatal mesencephalic grafts.
    Triarhou LC
    Adv Exp Med Biol; 2002; 517():43-61. PubMed ID: 12580306
    [No Abstract]   [Full Text] [Related]  

  • 50. A comparison of solid intraventricular and dissociated intraparenchymal fetal substantia nigra grafts in a rat model of Parkinson's disease: impaired graft survival is associated with high baseline rotational behavior.
    Heim RC; Willingham G; Freed WJ
    Exp Neurol; 1993 Jul; 122(1):5-15. PubMed ID: 8101821
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adrenal medulla graft induced recovery of function in an animal model of Parkinson's disease: possible mechanisms of action.
    Becker JB; Curran EJ; Freed WJ
    Can J Psychol; 1990 Jun; 44(2):293-310. PubMed ID: 2200596
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brain transplant.
    Kumar N; Narayanaswamy AS
    J Assoc Physicians India; 1994 May; 42(5):403-5. PubMed ID: 7829441
    [No Abstract]   [Full Text] [Related]  

  • 53. Neuropathology of fetal nigral grafts in patients with Parkinson's disease.
    Kordower JH; Freeman TB; Olanow CW
    Mov Disord; 1998; 13 Suppl 1():88-95. PubMed ID: 9613724
    [No Abstract]   [Full Text] [Related]  

  • 54. Trophism, transplantation, and animal models of Parkinson's disease.
    Bankiewicz K; Mandel RJ; Sofroniew MV
    Exp Neurol; 1993 Nov; 124(1):140-9. PubMed ID: 8282071
    [No Abstract]   [Full Text] [Related]  

  • 55. An antibody in the CSF of Parkinson's disease patients disappears following adrenal medulla transplantation.
    McRae-Degueurce A; Klawans HL; Penn RD; Dahlstrom A; Tanner CM; Goetz CG; Carvey PM
    Neurosci Lett; 1988 Nov; 94(1-2):192-7. PubMed ID: 3241668
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dopaminergic reinnervation of the globus pallidus by fetal nigral grafts in the rodent model of Parkinson's disease.
    Bartlett LE; Mendez I
    Cell Transplant; 2005; 14(2-3):119-27. PubMed ID: 15881421
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CNS immunological modulation of neural graft rejection and survival.
    Borlongan CV; Stahl CE; Cameron DF; Saporta S; Freeman TB; Cahill DW; Sanberg PR
    Neurol Res; 1996 Aug; 18(4):297-304. PubMed ID: 8875445
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of intracerebral transplantation of immature substantia nigra in rats with experimentally induced Parkinson's disease. II. Results of histopathological and histofluorescent studies.
    Dymecki J; Półtorak M; Puciłowski O; Markiewicz D; Kostowski W
    Neuropatol Pol; 1985; 23(2):181-9. PubMed ID: 3930995
    [No Abstract]   [Full Text] [Related]  

  • 59. Intrastriatal grafts of adrenal medulla in hemiparkinsonian rats--ultrastructural study.
    Jedrzejewska A; Dymecki J
    Acta Neurobiol Exp (Wars); 1990; 50(4-5):391-6. PubMed ID: 2130657
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of adrenal medulla grafts on plasma catecholamines and rotational behavior.
    Takashima H; Poltorak M; Becker JB; Freed WJ
    Exp Neurol; 1992 Oct; 118(1):24-34. PubMed ID: 1397173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.